Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Gille

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Applied Toxicology : JAT|December 10, 2015
Reconstituted high-density lipoprotein can elevate plasma alanine aminotransferase by transient depletion of hepatic cholesterol: role of the phospholipid componentEva Herzog, Ingo Pragst, Marcel Waelchli, et al.
Circulation Research|July 21, 2016
Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative ActivitySvetlana A Didichenko, Alexei V Navdaev, Alexandre M O Cukier, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|October 25, 2022
CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I TrialC Michael Gibson, Syed Hassan A Kazmi, Serge Korjian, et al.
JACC. Basic to Translational Science|April 30, 2025
Apolipoprotein A1 (CSL112) Increases Lecithin-Cholesterol Acyltransferase Levels in HDL Particles and Promotes Reverse Cholesterol TransportRommel A Mathias, Elena Velkoska, Svetlana A Didichenko, et al.
Endocrinology|July 26, 2013
GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytesMark K Nøhr, Maria H Pedersen, Andreas Gille, et al.
Journal of the American Heart Association|August 27, 2015
Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical TrialPierluigi Tricoci, Denise M D'Andrea, Paul A Gurbel, et al.
Nature Communications|May 24, 2017
Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1Cecilie Morland, Krister A Andersson, Øyvind P Haugen, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Applied Toxicology : JAT|December 10, 2015
Reconstituted high-density lipoprotein can elevate plasma alanine aminotransferase by transient depletion of hepatic cholesterol: role of the phospholipid componentEva Herzog, Ingo Pragst, Marcel Waelchli, et al.
Circulation Research|July 21, 2016
Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative ActivitySvetlana A Didichenko, Alexei V Navdaev, Alexandre M O Cukier, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|October 25, 2022
CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I TrialC Michael Gibson, Syed Hassan A Kazmi, Serge Korjian, et al.
JACC. Basic to Translational Science|April 30, 2025
Apolipoprotein A1 (CSL112) Increases Lecithin-Cholesterol Acyltransferase Levels in HDL Particles and Promotes Reverse Cholesterol TransportRommel A Mathias, Elena Velkoska, Svetlana A Didichenko, et al.
Endocrinology|July 26, 2013
GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytesMark K Nøhr, Maria H Pedersen, Andreas Gille, et al.
Journal of the American Heart Association|August 27, 2015
Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical TrialPierluigi Tricoci, Denise M D'Andrea, Paul A Gurbel, et al.
Nature Communications|May 24, 2017
Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1Cecilie Morland, Krister A Andersson, Øyvind P Haugen, et al.
Pageof 5